5 May – Webinar in connection with year-end report
Alligator hosted a webinar and conference call for investors, analysts, and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the interim report. The presentation was followed by a Q&A session.
The call will be held in English and a recording can be requested via ir@alligatorbioscience.com.
LATEST NEWS
Bulletin from the annual general meeting in Alligator Bioscience AB on 6 May 2026
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis …
Alligator Bioscience AB reports financial results for the period 1 January – 31 March 2026 and provides a business update
Mitazalimab momentum: Final OPTIMIZE‑1 outcomes were presented at ASCO GI 2026, with additional investigator‑initiated data acce …
Invitation to Alligator Bioscience’s earnings call on 5 May 2026
Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX), a clinical-stage biotechnology company developing tumor-directed immuno-oncol …